Aarey Drugs & Pharmaceuticals to consider Preferential Issue,
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 March 2024.Powered by Capital Market - Live News
Aarey Drugs & Pharmaceuticals standalone net profit rises 91.00% in the December 2023 quarter,
Net profit of Aarey Drugs & Pharmaceuticals rose 91.00% to Rs 1.91 crore in the quarter ended December 2023 as against Rs 1.00 crore during the previous quarter ended December 2022. Sales rose 22.43% to Rs 76.48 crore in the quarter ended December 2023 as against Rs 62.47 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales76.4862.47 22 OPM %3.542.45 - PBDT2.531.30 95 PBT1.470.75 96 NP1.911.00 91 Powered by Capital Market - Live News
Aarey Drugs & Pharmaceuticals schedules board meeting,
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News
Aarey Drugs & Pharmaceuticals to conduct EGM,
Aarey Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 29 December 2023 .Powered by Capital Market - Live News
Aarey Drugs & Pharmaceuticals standalone net profit declines 63.21% in the September 2023 quarter,
Net profit of Aarey Drugs & Pharmaceuticals declined 63.21% to Rs 0.78 crore in the quarter ended September 2023 as against Rs 2.12 crore during the previous quarter ended September 2022. Sales declined 24.17% to Rs 57.83 crore in the quarter ended September 2023 as against Rs 76.26 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales57.8376.26 -24 OPM %3.185.61 - PBDT2.272.75 -17 PBT1.002.33 -57 NP0.782.12 -63 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now